A company for life

We're a company that is built from within: leadership from key and relevant sectors and a business ethos that is managed with integrity.

Investment opportunity

Autolomous is led by highly knowledgeable founders. They bring together decades of advanced therapy manufacturing experience and enterprise-level technical expertise. Deploying this expertise within an agile start-up environment allows Autolomous to excel in a highly complex sector.

View the team
2019

Founded

24

Employees

13

Clients globally

Turning your ideas into reality

As global demand for advanced therapy treatments increases, Autolomous will equip ATMP manufacturers with the systems they will need to future-proof their business.

2019

Founded

24

Employees

13

Clients globally

Market opportunities

Autolomous is a proven startup, led by industry experts, which has demonstrated the need for an advanced therapy specific digital platform. In only two years since our inception we have already secured international advanced therapy manufacturers as trusted clients.

Growth enabler for ATMP industry

Autolomous provides a digital platform for data management within advanced therapy manufacturing, enabling the anticipated exponential growth of manufacturing operations.

Led by industry experts

Over the past 5 years, Autolomous has leveraged our industry networks to secure an international early adopter client base as well as innovation grant & support from UKRI (UK Research and Innovation).  

Market-leading team

The Autolomous team has grown to 24 team members in 5 years, with key roles now being filled by individuals from the advanced therapy industry to provide our clients reassurance and to accelerate our platform's development and adoption.

Trust, security and integrity

Autolomous is committed to managing its partnerships through trust and integrity. Our solutions ensure security and reliability both via the technology we employ and the quality, sustainability & information security management system adopted internally.

Roadmap

Highlights

ISO 9001, ISO 27001 & ISO 14001 certification

Autolomous has achieved ISO 9001:2015 and ISO 27001:2013 certification, as well as ISO 14001: 2015, demonstrating its dedication to the highest level of conformance with quality and security standards.

Growing Advanced Therapy industry

Sector financing reached $22.7B in 2021, a 14% increase over 2020 and a 55% increase over 2019. In the past 5 years, biopharma companies have spent $88 billion to acquire 15 early-stage cell therapy companies.

Consolidation of US presence

With US clients already secured, we are continuing to consolidate our presence in this market by establishing partnerships in the advanced therapy ecosystem with reputed suppliers.

Request an info pack

To delve further into what we do at Autolomous, contact us to request an info pack or to get more details.

Contact us